| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | CYP4X1 |
| Uniprot No | Q8N118 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-509aa |
| 氨基酸序列 | MEFSWLETRWARPFYLAFVFCLALGLLQAIKLYLRRQRLLRDLRPFPAPPTHWFLGHQKFIQDDNMEKLEEIIEKYPRAFPFWIGPFQAFFCIYDPDYAKTLLSRTDPKSQYLQKFSPPLLGKGLAALDGPKWFQHRRLLTPGFHFNILKAYIEVMAHSVKMMLDKWEKICSTQDTSVEVYEHINSMSLDIIMKCAFSKETNCQTNSTHDPYAKAIFELSKIIFHRLYSLLYHSDIIFKLSPQGYRFQKLSRVLNQYTDTIIQERKKSLQAGVKQDNTPKRKYQDFLDIVLSAKDESGSSFSDIDVHSEVSTFLLAGHDTLAASISWILYCLALNPEHQERCREEVRGILGDGSSITWDQLGEMSYTTMCIKETCRLIPAVPSISRDLSKPLTFPDGCTLPAGITVVLSIWGLHHNPAVWKNPKVFDPLRFSQENSDQRHPYAYLPFSAGSRNCIGQEFAMIELKVTIALILLHFRVTPDPTRPLTFPNHFILKPKNGMYLHLKKLSEC |
| 分子量 | 81.51 kDa |
| 蛋白标签 | GST-tag at N-terminal |
| 缓冲液 | 0 |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于重组人CYP4X1蛋白的3篇文献摘要简述：
1. **文献名称**: "Characterization of human cytochrome P450 CYP4X1: Expression, metabolism, and roles in tumor angiogenesis"
**作者**: Yanagisawa et al.
**摘要**: 研究通过重组表达技术成功在HEK293细胞中表达了人CYP4X1蛋白，发现其在多种肿瘤组织中特异性高表达，并可能通过代谢花生四烯酸类物质参与肿瘤血管生成调控。
2. **文献名称**: "Structural insights into human CYP4X1: A novel cytochrome P450 involved in fatty acid hydroxylation"
**作者**: Smith et al.
**摘要**: 利用X射线晶体学首次解析了重组人CYP4X1蛋白的三维结构，揭示了其在长链脂肪酸羟基化反应中的底物结合特异性，并阐明了其与CYP4家族其他成员的结构差异。
3. **文献名称**: "CYP4X1 regulates astrocyte-mediated neuroprotection in ischemic stroke"
**作者**: Zhang et al.
**摘要**: 通过重组蛋白功能实验发现，CYP4X1在中枢神经系统中参与二十碳五烯酸(EPA)代谢，可能通过调控小胶质细胞的抗炎反应发挥神经保护作用，为缺血性脑卒中的治疗提供新靶点。
注：CYP4X1的研究相对较少，以上为参考示例框架。如需真实文献，建议在PubMed中检索关键词"recombinant human CYP4X1"，近年研究多聚焦其在中枢神经系统代谢和肿瘤微环境中的功能。
Recombinant human CYP4X1 protein is a cytochrome P450 enzyme belonging to the CYP4 family, known for its role in metabolizing endogenous and exogenous compounds. Expressed heterologously in systems like *E. coli* or insect cells, the recombinant form enables detailed study of its structure and function, overcoming challenges posed by its low natural abundance in tissues such as the brain, vasculature, and lungs. CYP4X1 remains understudied compared to other CYP4 isoforms, but emerging evidence suggests its involvement in lipid metabolism, particularly in oxygenation of long-chain fatty acids, eicosanoids, and neuroprotective agents like *N*-acylethanolamines. It may regulate vascular tone by modulating arachidonic acid derivatives linked to vasodilation or constriction. Additionally, CYP4X1 has been implicated in pathological contexts, including tumor angiogenesis, neuroinflammation, and pulmonary hypertension, though its precise mechanisms remain unclear. Recombinant CYP4X1 serves as a critical tool for elucidating substrate specificity, catalytic activity, and inhibition profiles, aiding drug development and toxicology studies. Its unique substrate preference and tissue-specific expression highlight potential therapeutic targets for neurological or cardiovascular disorders. However, gaps persist in understanding its physiological relevance, regulatory pathways, and polymorphisms impacting enzyme activity, necessitating further research using recombinant protein models.
×
